Funding announcement
Curlew Bio Joins MTM's Brisbane Pod
Molecule to Medicine announces Curlew Bio as the second venture in its Brisbane Pod, with Uniquest Expansion Fund backing, to develop immunological therapies for inflammatory disease.
News publication
moleculetomedicine.com
Everything we hold that moleculetomedicine.com published.
Articles
Every article we hold from moleculetomedicine.com.
Rounds reported
Deals recorded from moleculetomedicine.com's coverage. A round is listed once, however many of their articles mention it.
| Company | Stage | Announced | Amount | Investors |
|---|---|---|---|---|
| Curlew Bio | Accelerator | undated | - |
Companies covered
Companies named in moleculetomedicine.com's articles, most-covered first.
| Company | What it does | Articles |
|---|---|---|
| UniQuest Extension Fund | 1 | |
| Molecule to Medicine | 1 | |
| Lucia Bio | Biotech developing Syk inhibitors to treat autoimmune, neuroinflammatory and hematologic … | 1 |
| Grey Wolf Therapeutics | 1 | |
| Curlew Bio | 1 |
Investors covered
Investors named in moleculetomedicine.com's articles, most-covered first.